GSK Faces More Headaches Over Avandia
GlaxoSmithKline PLC continues to face trouble after its diabetes drug, Avandia, was reported to increase the risk of heart attacks in patients. Another lawsuit was filed Monday, this time by a...To view the full article, register now.
Already a subscriber? Click here to view full article